[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2004, 30(4) 256-258 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
Toll������
�����
���������������
����
����ƽ
PubMed
Article by
Article by

Toll�������ڿ�ϵͳ�������Ⱦ�е�����

����, ����ƽ

���пƼ���ѧͬ��ҽѧԺ����ͬ��ҽԺƤ����, �人430030

ժҪ��

���귢�ֵ�Toll��������ϸ���������Ȼ���嵰��,��ʶ�����΢����ṹ�ͻ������Դ�Գɷ�,������֢�ź�,�鵼��������ѧЧӦ��Toll��������ʶ������ɷ�,�ڿ�ϵͳ�������Ⱦ����Ȼ�����з�����Ҫ����,ͬʱ,��Ҳ����Ȼ�������������ߵ����ӵ㡣ͨ����Toll��������о�,������̽�ֻ��忹ϵͳ�������Ⱦ�Ļ���,Ϊ�ٴ������ṩ��˼·��

�ؼ����� Toll������   �����  

Abstract:

Keywords:
�ո����� 2003-11-11 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����:
���߼��:

�ο����ף�
[1] Thoma-Uszynski S, Stenger S, Takeuchi O, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science,2001, 291:1544-1547.
[2] Rock FL, Hardiman G, Timans JC, et al. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A,1998, 95:588-593.
[3] Underhill DM, Ozinsky A, Hajjar AM, et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature, 1999, 401:811-815.
[4] Tada H, Nemoto E, Shimanchi H, et al. Saccharomyces cerevisiaeand Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14-and Toll-like receptor 4-dependent manner. Microbiol Immunol, 2002,46:503-512.
[5] Wang JE, Warris A, Ellingsen EA, et al. Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun, 2001, 69:2402-2406.
[6] Netea MG, Van Der Graaf CA, Vonk AG, et al. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J hffect Dis, 2002, 185:1483-1489.
[7] Shoham S, Huang C, Chen JM, et al. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol, 2001, 166:4620-4626.
[8] Ozato K, Tsujimura H, Tamura T. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. Biotechniques, 2002, Supp1:66-72.
[9] Toshchakov V, Jones BW, Lentschat A, et al. TLR2 and TLR4 agonists stimulate unique repertoires of host resistance genes in murine macrophages:interferon-beta-dependent signaling in TLR4-mediated responses. J Endotoxin Res, 2003, 9:169-175.
[10] Kurt-Jones EA, Mandell L, Whitney C, et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation:GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils.Blood, 2002, 100:1860-1868.
[11] Fan J, Malik AB. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat Med, 2003, 9:315-321.
[12] Sabroe I, Prince LR, Jones EC, et al. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol, 2003, 170:5268-5275.
[13] Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate human neutrophil function. Blood, 2003, 102:2660-2669.
[14] Jones BW, Means TK, Heldwein KA, et al. Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol,2001, 69:1036-1044.
[15] Noss EH, Pai RK, Sellati TJ, et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol, 2001, 167:910-918.
[16] Supajatura V, Ushio H, Nakao A, et al. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol, 2001, 167:2250-2256.
[17] Werling D, Jungi TW. TOLL-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol, 2003, 91:1-12.
[18] Thoma-Uszynski S, Kiertscher SM, Ochoa MT et al. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol, 2000, 165:3804-3810.
[19] Visintin A, Mazzoni A, Spitzer JH, et al. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol, 2001,166:249-255.
[20] Boonstra A, Asselin-Paturel C, Gilliet M, et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development:dependency on antigen dose and differential toll-like receptor ligation. J Exp Med, 2003, 197:101-109.
�������������
1����ӱ�,֣��.��м������������Toll������[J]. ����Ƥ���Բ�ѧ��־, 2008,34(2): 89-91
2��������,������.Toll�����������ѧ�о���չ[J]. ����Ƥ���Բ�ѧ��־, 2008,34(2): 92-94
3����ϼ,Ҧ־��.Toll�������뿹���������Ⱦ[J]. ����Ƥ���Բ�ѧ��־, 2008,34(5): 333-335
4������ ������ ����Ȫ ���� ��ǧ��.÷�����߰׽���4��Toll������2���򵥺������̬���о�[J]. ����Ƥ���Բ�ѧ��־, 2010,36(6): 306-308
5����ʥ ������.Toll������9��ϵͳ�Ժ���Ǵ�[J]. ����Ƥ���Բ�ѧ��־, 2006,32(6): 356-356
6����ͮ��.ϸ����ģʽʶ������NOD2������Ƥ�����е�����[J]. ����Ƥ���Բ�ѧ��־, 2007,33(2): 104-104
7����С��, ֣��.Toll����������������[J]. ����Ƥ���Բ�ѧ��־, 2003,29(2): 106-109
8��³����, ��С��, ֣��.CpG DNA��ϵͳ�Ժ���Ǵ������е�����[J]. ����Ƥ���Բ�ѧ��־, 2004,30(6): 360-362
9����ʢ, ����֥.Toll��������÷������[J]. ����Ƥ���Բ�ѧ��־, 2005,31(3): 139-141
10������, ������.Toll�������ijЩƤ�����Ĺ�ϵ[J]. ����Ƥ���Բ�ѧ��־, 2005,31(4): 259-261
11���ܱ���, �浤.Toll��������Ƥ������Ⱦ����[J]. ����Ƥ���Բ�ѧ��־, 2006,32(1): 51-53
12����ʥ, ������.Toll������9��ϵͳ�Ժ���Ǵ�[J]. ����Ƥ���Բ�ѧ��־, 2006,32(6): 356-358
13��������, ��־ǿ.ϸ����ģʽʶ������NOD2������Ƥ�����е�����[J]. ����Ƥ���Բ�ѧ��־, 2007,33(2): 104-106
14����ɯ ������.Toll������7��Ƥ�������о���չ[J]. ����Ƥ���Բ�ѧ��־, 2015,41(2): 118-120
15���׾� �ǽ��� ����.����ͷ��������Ⱦ�����������߷�Ӧ[J]. ����Ƥ���Բ�ѧ��־, 2015,41(2): 137-140

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־